[go: up one dir, main page]

WO2016190583A1 - Dispositif d'administration d'insuline et dispositif électronique communiquant avec celui-ci - Google Patents

Dispositif d'administration d'insuline et dispositif électronique communiquant avec celui-ci Download PDF

Info

Publication number
WO2016190583A1
WO2016190583A1 PCT/KR2016/005161 KR2016005161W WO2016190583A1 WO 2016190583 A1 WO2016190583 A1 WO 2016190583A1 KR 2016005161 W KR2016005161 W KR 2016005161W WO 2016190583 A1 WO2016190583 A1 WO 2016190583A1
Authority
WO
WIPO (PCT)
Prior art keywords
insulin
information
insulin administration
user
biometric information
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2016/005161
Other languages
English (en)
Korean (ko)
Inventor
김도윤
조철호
백인걸
김용
조재걸
강재은
이정은
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Samsung Electronics Co Ltd
Original Assignee
Samsung Electronics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Samsung Electronics Co Ltd filed Critical Samsung Electronics Co Ltd
Publication of WO2016190583A1 publication Critical patent/WO2016190583A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic

Definitions

  • Various embodiments of the present disclosure relate to an insulin administration device and an electronic device that communicates with the insulin administration device, and more particularly, based on biometric information of a user, insulin administration information may be set and abnormality of insulin administration may be determined.
  • An insulin administration device and an electronic device in communication with the insulin administration device in communication with the insulin administration device.
  • diabetics lack the ability to produce insulin to control blood sugar levels, and thus, normal blood sugar control functions are not achieved. Accordingly, by administering insulin to a diabetic patient using an insulin administration device, blood glucose levels are maintained at a normal level.
  • Whether or not insulin is administered depends on the results of blood glucose measurements. Blood glucose is measured, and the measured blood sugar level is compared with the normal blood sugar level to determine whether insulin is administered, and insulin is administered.
  • Conventional insulin administration device is to administer a predetermined amount of insulin in accordance with the setting by the manual operation of the user, it does not take into account the change in the health status of the patient in real time.
  • an insulin administration device and an insulin administration device capable of setting insulin administration information in consideration of the user's biometric information, and determining whether there is an abnormality in insulin administration based on the biometric information of the user after insulin administration It is possible to provide an electronic device in communication with the.
  • the patient's condition is measured to determine whether there is an abnormality, and the abnormality is fed back to the user, whereby appropriate response can be made to an adverse reaction such as hypoglycemia after insulin administration.
  • FIG. 1A is a diagram illustrating an insulin administration system according to one embodiment.
  • 1B is a diagram illustrating a structure of an insulin administration device according to one embodiment.
  • FIG. 2 is a flowchart illustrating a method of operating the insulin administration device of FIG. 1.
  • FIG. 3 is a flowchart illustrating a method of operating the insulin administration system of FIG. 1.
  • FIG. 4 is a diagram illustrating an insulin administration system according to one embodiment.
  • FIG. 5 is a flowchart illustrating a method of operating the electronic device of FIG. 4.
  • FIG. 6 is a flowchart illustrating a method of operating the insulin administration system of FIG. 4.
  • FIG. 7 is a flowchart illustrating a method of operating an insulin administration device when insulin administration information is manually set in step 650 of FIG. 6 (S650).
  • FIG. 8 is a diagram illustrating an insulin administration system according to one embodiment.
  • FIG. 9 is a flowchart illustrating a method of operating the insulin administration system of FIG. 8.
  • FIG. 10 is a diagram illustrating an insulin administration system according to one embodiment.
  • FIG. 11 is a flowchart illustrating a method of operating the insulin administration system of FIG. 10.
  • FIG. 12 is a diagram illustrating an example of changing insulin administration information based on biometric information of a user, according to an exemplary embodiment.
  • FIG. 13 is a diagram illustrating an example in which an insulin administration device receives biometric information after completion of insulin administration.
  • FIG. 14 is a diagram illustrating an example in which insulin administration information is set based on biometric information of a user, according to an exemplary embodiment.
  • 15 is a diagram illustrating an example of manually setting insulin administration information in an insulin administration device according to one embodiment.
  • 16 is a diagram illustrating an example in which an electronic device receives biometric information after completion of insulin administration according to one embodiment.
  • 17A and 17B illustrate an example of feeding back side effects to a user when side effects occur due to insulin administration, according to an exemplary embodiment.
  • FIG. 18 is a diagram illustrating an example of transmitting a message informing of occurrence of side effects to an external device when side effects occur in administering insulin according to an embodiment.
  • 19A, 19B, and 20 are diagrams illustrating an authentication method between an insulin administration device and an electronic device according to an embodiment.
  • 21 and 22 are block diagrams showing the configuration of an insulin administration device according to one embodiment.
  • 23 and 24 are block diagrams illustrating a configuration of an electronic device according to an embodiment of the present invention.
  • the insulin administration device In response to detecting the completion of insulin administration, the insulin administration device according to an embodiment requests a biometric information measurement of a user to a biometric information measuring device, and receives the biometric information from the biometric information measuring device based on the received biometric information.
  • the control unit may determine whether there is an abnormality for the user and an output unit which outputs a determination result of the abnormality.
  • the control unit sets the insulin administration information based on the biometric information of the user measured before the insulin administration, and the insulin prescription information for the user, the insulin administration information is insulin administration time, type of insulin to be administered It may include at least one of, the insulin dose and the mixing ratio of insulin.
  • the communication unit may receive the insulin prescription information from an external device.
  • Insulin administration device may further include a user input for receiving insulin prescription information.
  • the output unit may include a display unit displaying the set insulin administration information.
  • the output unit may display the determination result on the display unit or output the audio or vibration signal.
  • Insulin administration device further comprises a sensor unit for sensing whether the needle coupled to the insulin administration device is in contact with the body of the user,
  • the controller may determine that the insulin administration is completed when the needle is not in contact with the body of the user for a time set by the user.
  • the controller may determine that the insulin administration is completed when at least one of the case where the insulin dose included in the set insulin administration information is administered and when the insulin administration completion input is received.
  • a method of operating an insulin administration device comprising: detecting completion of insulin administration, requesting measurement of biometric information of a user by a biometric information measurement device, receiving biometric information from the biometric information measurement device, and receiving The method may include determining whether there is an abnormality with respect to the user based on the biometric information and outputting a determination result of the abnormality.
  • the electronic device receives insulin administration completion information from an insulin administration device, and upon receiving the insulin administration completion information, requests a biometric information measurement of a user from a biometric information measurement device. It may include a communication unit for receiving biometric information, a control unit for determining whether there is an abnormality for the user based on the received biometric information, and an output unit for outputting the determination result of the abnormality.
  • the electronic device may further include a storage configured to store insulin administration history information of the user, and the controller may update the insulin administration history information when the insulin administration completion information is received.
  • the communication unit may receive insulin prescription information for the user from a prescription server.
  • the controller may control to transmit a message to the terminal set by the user through the communication unit.
  • a method of operating an electronic device may include receiving insulin administration completion information from an insulin administration device, and when receiving the insulin administration completion information, requesting measurement of a user's biometric information by a biometric information measuring device.
  • the method may include receiving the biometric information from an information measuring device, determining whether there is an abnormality for the user based on the received biometric information, and outputting a determination result regarding the abnormality.
  • any part of the specification is to “include” any component, this means that it may further include other components, except to exclude other components unless otherwise stated.
  • the terms “... unit”, “module”, etc. described in the specification mean a unit for processing at least one function or operation, which may be implemented in hardware or software or a combination of hardware and software. .
  • FIG. 1A is a diagram illustrating an insulin administration system, according to one embodiment.
  • Insulin administration system may include an insulin administration device 100 and the biometric information measuring device 50.
  • Insulin administration device 100 means a device that can inject insulin to the patient. The structure of the insulin administering device 100 will be described later with reference to FIG. 1B.
  • the insulin administration device 100 may include a pen-type insulin pen and a pump-type insulin pump. However, the present invention is not limited thereto, and the insulin administration device may be implemented in various forms.
  • Insulin administration device 100 may include a communication module that can communicate with an external device or server.
  • the insulin administration device 100 may communicate with an external device or server to receive insulin prescription information (eg, insulin administration information prescribed by a doctor) of the user.
  • the insulin administration device 100 communicates with the biometric information measuring device 50, requests the biometric information measuring device 50 to measure the biometric information of the user, and transmits the biometric information of the user from the biometric information measuring device 50. Information can be received.
  • the insulin administration device 100 may receive first biometric information sensed before insulin administration and second biometric information sensed after insulin administration.
  • the insulin administration device 100 may set insulin administration information based on the insulin prescription information and the user's first biometric information (biometric information sensed prior to insulin administration).
  • Insulin administration information may include insulin administration time, type of insulin to be administered, insulin dose, mixing ratio of different insulins (when different types of insulin are mixed), and the like.
  • Insulin administration device 100 may control to administer the insulin to the user, according to the set insulin administration information.
  • the insulin administration device 100 may determine whether there is an abnormality in insulin administration based on the second biometric information of the user (the biometric information sensed after the insulin administration).
  • the biometric information measuring device 50 may include the user's biometric information (eg, a user's body temperature, heart rate, pulse rate, pulse variability, blood pressure, sweat, blood sugar, respiration information, oxygen saturation, skin condition, and exercise amount information). , Diet information, meal amount information, stress information, sleep information, etc.).
  • the biometric information measuring device 50 may include various sensors capable of measuring biometric information of a user.
  • the biometric information measuring device 50 may be implemented as a wearable device.
  • the biometric information measuring device 50 may be implemented as a wrist watch, glass, ring, bracelet, necklace, headband, patch, clip, earphone, hat, helmet, clothing, shoes, and the like.
  • the biometric information measuring device 50 may include a communication module capable of communicating with an external device or a server.
  • the biometric information measuring device 50 may communicate with the insulin administering device 100 to receive a user's biometric information request from the insulin administering device 100.
  • the biometric information measuring device 50 may measure the biometric information of the user.
  • the biometric information of the user may be measured and stored at a predetermined cycle.
  • the biometric information measuring device 50 may transmit the biometric information to the insulin administering device 100.
  • 1B is a diagram illustrating a structure of an insulin administration device according to one embodiment.
  • the insulin administering device 100 includes a driving unit 300 and a piston pushing unit 400.
  • the driver 300 includes a battery, and includes a motor, a controller, and a display 350.
  • the control unit receives the information input by the user and processes it to drive the motor.
  • the driving unit 300 is coupled to the piston pushing unit 400 to transmit the rotational force of the motor to the piston pushing unit 400 through the gearbox.
  • the controller may control the rotation of the motor according to the set insulin administration information so as to administer the desired amount of insulin.
  • the display 350 may display insulin administration information such as insulin dose.
  • the piston pushing unit 400 may include a cartridge holder 460, and the cartridge 1 having insulin therein may be detachably mounted to the cartridge holder 460.
  • the cover 101 may be inserted into the piston pushing unit 400 to protect the insulin administration device 100.
  • the injection amount indicator 250 has a hollow cylindrical shape and is rotatably mounted.
  • the upper side of the outer circumferential surface of the injection amount display unit 250 is provided with an injection amount display unit displayed at equal intervals in the insulin injection amount according to the rotational angle, and a handle portion is formed on the lower side to facilitate the user's rotation.
  • the cartridge holder 260 is detachably coupled to the cartridge connector 220 with screws, and accommodates the cartridge 1 containing insulin.
  • the outer circumferential surface of the cartridge fixing body 260 may be provided with a remaining amount checking hole for checking the remaining amount of insulin of the cartridge 1 accommodated therein.
  • the needle connector 470 is fixed to the lower side of the cartridge holder 460 and is detachably coupled with a screw. A needle may be coupled to the needle connector 460, and the needle coupled to the needle connector 460 may be inserted into the body of the user to administer insulin to the user.
  • FIG. 2 is a flowchart illustrating a method of operating the insulin administration device of FIG. 1.
  • the insulin administration device 100 may receive insulin prescription information and first biometric information of the user (S210).
  • the insulin prescription information may be received from an external device or a server, or the user may directly input the insulin administration device 100.
  • the insulin prescription information may be information about insulin to be administered to the user in order to maintain the blood sugar of the user, and may be used by the insulin administration device 100 to set insulin administration information.
  • the insulin prescription information may include, for example, insulin administration time, type of insulin to be administered, insulin dosage amount, and mixing ratio of different insulins (when different types of insulin are mixed and administered).
  • the present invention is not limited thereto and various information related to insulin administration may be included in the insulin prescription information.
  • the insulin administration device 100 may receive the first biometric information of the user from the biometric information measuring device 50.
  • the first biometric information may be biometric information of the user sensed prior to insulin administration.
  • the insulin administering device 100 requests the biometric information measurement of the user to the biometric information measuring device 50 at a point in time at which the insulin is administered or at a certain time before the administration time of the insulin.
  • the biometric information of the user may be received from 50.
  • the insulin administration device 100 may set insulin administration information based on the insulin prescription information and the first biometric information of the user (S220).
  • the insulin administration device 100 may change insulin based on the first biometric information, wherein at least one of the insulin administration time, the type of insulin to be administered, the insulin dose, and the mixing ratio of different insulins included in the prescription information is changed.
  • Dosing information can be set.
  • the insulin administration device 100 may set the administration information by reducing the dose of insulin included in the insulin prescription information in consideration of the first biometric information such as blood sugar level, exercise time, and intensity before exercise of the user. have. In this case, the insulin administration device 100 may automatically set the changed administration information.
  • the insulin administration device 100 may display the changed administration information on the display unit. When the changed administration information is displayed on the display unit, the user may confirm the changed administration information and manually set the changed administration information in the insulin administration device 100.
  • the insulin administration device 100 changes the format of the insulin prescription information to the format of the insulin administration information, and changes the changed information and the first living body. Based on the information, insulin administration information can be set. For example, in the insulin prescription information, the dosage and the time of administration are prescribed based on the first insulin, but the insulin used in the insulin administration device 100 is the second insulin (for example, insulin different from the first insulin). ), The insulin administration device 100 may change insulin prescription information (eg, insulin dosage amount, insulin administration time, etc.) based on the second insulin. The insulin administration device 100 may set insulin administration information based on the changed prescription information and the first biometric information based on the second insulin.
  • insulin prescription information eg, insulin dosage amount, insulin administration time, etc.
  • Insulin administration device 100 may control to administer the insulin to the user according to the set administration information (S230).
  • the insulin administration device 100 may obtain second biometric information of the user (S240).
  • the insulin administration device 100 may determine that insulin administration is complete when the injection port for administering insulin is not contacted from the user's body for a time set by the user. Alternatively, when all of the set insulin dose is administered to the user, it may be determined that insulin administration is completed. Alternatively, when the insulin administration completion input is received, it may be determined that insulin administration completion.
  • the insulin administration device 100 When the insulin administration is completed, the insulin administration device 100 requests the biometric information measurement to the biometric information measuring device 50, and the biometric information (second biometric information) of the user after the insulin administration from the biometric information measuring device 50 Can be received.
  • the insulin administration device 100 may receive a blood glucose level of the user after insulin administration from the biometric information measuring device 50.
  • the insulin administration apparatus 100 may determine whether there is an abnormality in administration of insulin based on the acquired biometric information of the user, and output the determination result (S250).
  • the insulin administration device 100 may determine an abnormal state (side effect) and display a side effect occurrence message on the display unit.
  • the insulin administration device 100 may output audio, vibration, or the like indicating side effects.
  • FIG. 3 is a flowchart illustrating a method of operating the insulin administration system of FIG. 1.
  • the insulin administration device 100 may receive insulin prescription information (S310).
  • the insulin prescription information may be received from an external device or a server, or the user may directly input the insulin administration device 100.
  • Insulin prescription information indicates insulin administration information for the user, and may include insulin administration time, type of insulin to be administered, insulin dosage, and insulin mixing ratio (when different types of insulin are mixed and administered). Can be.
  • Insulin administration device 100 may request the biometric information of the user to the biometric information measuring device 50 at a time of administration, or a time before the administration time (S320).
  • the biometric information measuring apparatus 50 may measure the biometric information of the user in response to the biometric information request (S330), or may measure and store the biometric information of the user at a predetermined cycle even if there is no biometric information request.
  • the biometric information measuring device 50 may transmit the biometric information of the user to the insulin administration device 100 (S340).
  • the insulin administration device 100 may set insulin administration information based on the insulin prescription information and the user's biometric information (S350). Since operation 350 of FIG. 3 (S350) corresponds to operation 220 of FIG. 2 (S220), a detailed description thereof will be omitted.
  • the insulin administration device 100 may control to administer the insulin to the user according to the set administration information (S360), and when the insulin administration is completed, request the biometric information measurement to the biometric information measuring device 50 (S370).
  • the biometric information measuring device 50 may measure biometric information (eg, blood sugar level, respiratory rate, pulse rate, and the like) related to blood sugar of the user (S375) and transmit the same to the insulin administration device 100. (S380).
  • biometric information eg, blood sugar level, respiratory rate, pulse rate, and the like
  • the insulin administration device 100 may determine whether there is an abnormality in insulin administration based on the biometric information of the user received from the biometric information measuring device 50, and output the determination result (S390). Since step 390 (S390) corresponds to step 250 of FIG. 2 (S250), a detailed description thereof will be omitted.
  • FIG. 4 is a diagram illustrating an insulin administration system according to one embodiment.
  • the system may include an insulin administration device 100, an electronic device 200, and a biometric information measurement device 50. Since the insulin administration device 100 and the biometric information measurement device 50 have been described in detail with reference to FIG. 1, the same description will be omitted.
  • the electronic device 200 includes a mobile phone, a smart phone, a laptop computer, a tablet PC, an electronic book terminal, a digital broadcasting terminal, a personal digital assistant (PDA), and a portable multimedia player (PMP). ), Navigation, MP3 player, digital camera, IPTV (Internet Protocol Television), DTV (Digital Television), CE devices (eg, refrigerators with display devices, Aiken, etc.), but are not limited thereto.
  • PDA personal digital assistant
  • PMP portable multimedia player
  • Navigation MP3 player
  • digital camera digital camera
  • IPTV Internet Protocol Television
  • DTV Digital Television
  • CE devices eg, refrigerators with display devices, Aiken, etc.
  • the electronic device 200 may be a wearable device.
  • the electronic device 200 may be a wrist watch, glass, ring, bracelet, necklace, headband, or the like.
  • the electronic device 200 may include a communication module for communicating with an external device or a server.
  • the electronic device 200 may communicate with an external device or server to receive insulin prescription information of the user.
  • the electronic device 200 communicates with the biometric information measuring device 50, requests biometric information of the user from the biometric information measuring device 50, and receives the biometric information of the user from the biometric information measuring device 50. Can be received.
  • the electronic device 200 may set insulin administration information based on the insulin prescription information and the user's biometric information (first biometric information).
  • the insulin administration information may include insulin administration time, insulin type to be administered, insulin dosage amount, insulin mixing ratio (when different types of insulin are mixed), and the like.
  • the electronic device 200 may communicate with the insulin administration device 100 to transmit the set administration information to the insulin administration device 100.
  • the electronic device 200 may determine whether a side effect of insulin administration occurs based on the biometric information (second biometric information) of the user measured by the biometric information measuring device 50 after insulin administration.
  • FIG. 5 is a flowchart illustrating a method of operating the electronic device of FIG. 4.
  • the electronic device 200 may receive insulin prescription information and biometric information of a user (S510).
  • insulin prescription information may be received from an external device or a server, or may be input directly by the user to the electronic device 200.
  • the electronic device 200 may receive the first biometric information of the user from the biometric information measuring device 50.
  • the biometric information measuring device 50 is requested to measure the biometric information of the user, and the biometric information of the user from the biometric information measuring device 50 is determined. Information can be received.
  • the electronic device 200 may set insulin administration information based on the insulin prescription information and the first biometric information of the user (S520).
  • the electronic device 200 based on the first biometric information, the insulin administration time included in the insulin prescription information, the type of insulin to be administered, the insulin dose, and the mixing ratio of insulin (mixing different kinds of insulins). At least one of the administration information may be set.
  • the electronic device 200 may set the administration information by reducing the dose of insulin included in the insulin prescription information in consideration of first biometric information such as blood glucose level, exercise time, and intensity before exercise of the user. .
  • the electronic device 200 may transmit the changed administration information to the insulin administration device 100 (S530). Alternatively, the electronic device 200 may display the changed administration information on the display unit of the electronic device 200. When the changed administration information is displayed on the display unit, the user may confirm the changed administration information and set the changed administration information in the insulin administration device 100.
  • the electronic device 200 may receive the administration completion information from the insulin administration device 100 or may receive a user input to detect completion of insulin administration (S540).
  • the electronic device 200 may acquire the biometric information of the user after insulin administration (S550).
  • the electronic device 200 may request biometric information measurement from the biometric information measuring device 50 and receive biometric information of a user after insulin administration from the biometric information measuring device 50.
  • the electronic device 200 may receive a blood sugar level of the user from the biometric information measuring device 50.
  • the user may directly input the user's biometric information measured by the biometric information measuring device 50 to the electronic device 200.
  • the electronic device 200 may determine whether a side effect of insulin administration occurs based on the received biometric information of the user after insulin administration, and output a determination result (S560).
  • the electronic device 200 determines that the side effect occurs (abnormal state), and a graphic element indicating the occurrence of the side effect. (Eg, a menu, an icon, text, an item, etc.) may be displayed on the display unit 221.
  • the electronic device 200 may output audio, vibration, or the like indicating side effects.
  • the electronic device 200 may transmit a side effect occurrence message to a preset external device.
  • FIG. 6 is a flowchart illustrating a method of operating the insulin administration system of FIG. 4.
  • the electronic device 200 may obtain insulin prescription information (S610).
  • insulin prescription information may be received from an external device or a server, or may be input directly by the user to the electronic device 200.
  • Insulin prescription information indicates insulin administration information for the user, and may include insulin administration time, type of insulin to be administered, insulin dosage, and insulin mixing ratio (when different types of insulin are mixed and administered). Can be.
  • the electronic device 200 may request the biometric information of the user from the biometric information measuring device 50 at a time of administration or a predetermined time before the time of administration (S620).
  • the biometric information measuring apparatus 50 may measure the biometric information of the user in response to the biometric information request (S630), or may measure and store the biometric information of the user at a predetermined cycle even if there is no biometric information request.
  • the biometric information measuring device 50 may transmit the biometric information of the user to the electronic device 200 (S635).
  • the electronic device 200 may set insulin administration information based on the insulin prescription information and the received biometric information of the user (S640). Since step 640 (S640) corresponds to step 520 (S520) of FIG. 5, a detailed description thereof will be omitted.
  • the electronic device 200 may transmit the insulin administration information to the insulin administration device 100 (S645). Alternatively, the electronic device 200 may display the changed administration information on the display unit of the electronic device 200.
  • the insulin administration device 100 may automatically set administration information received from the electronic device 200 (S650), or display the received administration information on the display unit.
  • the user may confirm the changed administration information and manually set the changed administration information.
  • Insulin administration device 100 may administer insulin to the user according to the set administration information (S655).
  • the insulin administration device 100 may transmit the administration completion information to the electronic device 200 (S660).
  • the electronic device 200 may request the biometric information measurement of the user from the biometric information measuring device 50 (S665). Accordingly, the biometric information measuring device 50 may measure the biometric information of the user (S667) and transmit the biometric information to the electronic device 200 (S670). For example, the biometric information measuring device 50 may transmit the blood sugar level of the user to the electronic device 200.
  • the electronic device 200 may determine whether there is an abnormality in insulin administration based on the received biometric information of the user, and output the determination result (S680). Since step 680 (S680) corresponds to step 560 (S560) of FIG. 5, a detailed description thereof will be omitted.
  • FIG. 7 is a flowchart illustrating a method of operating an insulin administration device when insulin administration information is manually set in step 650 of FIG. 6 (S650).
  • Insulin administration device 100 may receive the first administration information (S710).
  • the first administration information may be insulin administration information set in the electronic device 200.
  • Insulin administration device 100 may receive the second administration information (S720).
  • the second administration information may be administration information input by the user to the insulin administration device 100.
  • the insulin administration device 100 may determine whether the first administration information and the second administration information match within a predetermined range (S730).
  • the insulin administration device 100 may display a notification message (S740). For example, a message indicating that the administration information is entered incorrectly may be displayed on the display unit.
  • the insulin administration device 100 may set the second administration information as insulin administration information (S750).
  • FIG. 8 is a diagram illustrating an insulin administration system according to one embodiment.
  • An insulin administration system may include an insulin administration device 100, a biometric information measurement device 50, and a server 300. Since the insulin administration device 100 and the biometric information measurement device 50 have been described in detail with reference to FIG. 1, the same description will be omitted.
  • the server 300 may be a prescription server or a clinical decision support system (CDSS) server.
  • the prescription server is a server that manages a user's prescription.
  • the prescription server may receive and store a user's prescription from a medical staff, and transmit the user's prescription to the electronic device 200 or the insulin administration device 100 of the user.
  • CDSS server is a server that provides the medical knowledge necessary when the doctor decides and judges the diagnosis or treatment policy about the patient's specific problem, to derive the best solution and provide the derived solution to the user. Can be.
  • the server 300 may include a communication module that may communicate with the insulin administration device 100 or the biometric information measurement device 50.
  • the server 300 may transmit insulin prescription information to the insulin administration device 100, and may receive biometric information of the user from the insulin administration device 100 or the biometric information measurement device 50.
  • the server 300 may change the insulin prescription information based on the received biometric information of the user. In addition, the changed insulin prescription information may be transmitted to the insulin administration device 100.
  • FIG. 9 is a flowchart illustrating a method of operating the insulin administration system of FIG. 8.
  • the insulin administration device 100 may receive insulin prescription information (S910).
  • the insulin prescription information may be received from an external device or the server 300, or the user may directly input the insulin administration device 100.
  • Insulin prescription information indicates insulin administration information for the user, and may include insulin administration time, type of insulin to be administered, insulin dosage, and insulin mixing ratio (when different types of insulin are mixed and administered). Can be.
  • Insulin administration device 100 may request the biometric information of the user to the biometric information measuring device 50 at a time of administration, or a time before the administration time (S920).
  • the biometric information measuring apparatus 50 may measure the biometric information of the user in response to the biometric information request (S925), or may measure and store the biometric information of the user at a predetermined cycle even if there is no biometric information request.
  • the biometric information measuring device 50 may transmit the biometric information of the user to the insulin administration device 100 (S930).
  • the insulin administration device 100 may transmit the user's biometric information received from the biometric information measuring device 50 to the server 300.
  • the biometric information measuring device 50 may transmit the biometric information of the user to the server 300.
  • the server 300 may change the insulin prescription information of the user based on the received biometric information of the user (S940). For example, the server 300 may change the insulin prescription information by reducing the dose of insulin included in the insulin prescription information in consideration of the user's pre-workout blood sugar level, exercise time, and intensity. The server 300 may transmit the changed prescription information to the insulin administration device 100 (S945).
  • the insulin administration device 100 may set insulin administration information according to the changed prescription information. At this time, the insulin administration device 100 may automatically set the changed prescription information (S950). Alternatively, the insulin administration device 100 may display the changed prescription information on the display unit. When the changed prescription information is displayed on the display unit, the user may confirm the changed insulin prescription information and manually set the insulin administration information.
  • Insulin administration device 100 may control to administer the insulin to the user according to the set administration information (S955).
  • the insulin administration device 100 requests the biometric information measurement to the biometric information measuring device 50 (S960), the biometric information measuring device 50 to measure the biometric information of the user after insulin administration. It may be (S962).
  • the insulin administration device 100 may receive biometric information from the biometric information measuring device 50 (S965).
  • the insulin administration device 100 may receive a blood sugar level of the user from the biometric information measurement device 50.
  • the insulin administration device 100 may determine whether there is an abnormality based on the acquired biometric information of the user, and output the determination result (S970).
  • the insulin administration device 100 determines that the user's blood sugar level is less than the threshold value, and determines that an abnormal state (side effect) occurs, and graphic elements (eg, menus, icons, texts, items, etc.) indicating side effects occur. ) Can be displayed.
  • the insulin administration device 100 may output audio, vibration, or the like indicating side effects.
  • FIG. 10 is a diagram illustrating an insulin administration system according to one embodiment.
  • An insulin administration system may include an insulin administration device 100, an electronic device 200, a biometric information measurement device 50, and a server 300.
  • the electronic device 200 may include a communication module to communicate with the server 300, the insulin administering device 100, and the biometric information measuring device 50.
  • the electronic device 200 may communicate with the external device or the server 300 to receive insulin prescription information of the user.
  • the electronic device 200 communicates with the biometric information measuring device 50, requests biometric information of the user from the biometric information measuring device 50, and receives the biometric information of the user from the biometric information measuring device 50. Can be received.
  • the server 300 may receive biometric information of the user from the electronic device 200 or the biometric information measuring device 50.
  • the server 300 may change the insulin prescription information of the user based on the received biometric information of the user.
  • the changed insulin prescription information may be transmitted to the electronic device 200.
  • FIG. 11 is a flowchart illustrating a method of operating the insulin administration system of FIG. 10.
  • the electronic device 200 may receive insulin prescription information (S1110).
  • the insulin prescription information may be received from an external device or the server 30 or may be input directly by the user to the electronic device 200.
  • Insulin prescription information indicates insulin administration information for the user, and includes insulin administration time, type of insulin to be administered, insulin dosage, and insulin mixing ratio (when different types of insulin are mixed and administered). can do.
  • the electronic device 200 may request the biometric information of the user from the biometric information measuring device 50 at a time of administration or a time before the time of administration (S1115).
  • the biometric information measuring apparatus 50 may measure the biometric information of the user in response to the biometric information request (S1120) or may measure and store the biometric information of the user at a predetermined cycle even if there is no biometric information request.
  • the biometric information measuring device 50 may transmit the biometric information of the user to the electronic device 200 (S1125).
  • the electronic device 200 may transmit the user's biometric information received from the biometric information measuring device 50 to the server 300 (S1130).
  • the biometric information measuring device 50 may transmit the biometric information of the user to the server 300.
  • the server 300 may change the insulin prescription information of the user based on the received biometric information of the user (S1135). For example, the server 300 may change the insulin prescription information by reducing the dose of insulin included in the prescription information in consideration of the user's pre-workout blood sugar level, exercise time, and intensity. The server 300 may transmit the changed insulin prescription information to the electronic device 200 (S1140).
  • the electronic device 200 may set insulin administration information based on the changed prescription information in operation S1145.
  • the electronic device 200 may transmit the administration information to the insulin administration device 100 (S1150). Alternatively, the electronic device 200 may display the administration information on the display unit of the electronic device 200. When the administration information is displayed on the display unit, the user may confirm the administration information and set the changed administration information in the insulin administration device 100 (S1155).
  • Insulin administration device 100 may control to administer the insulin to the user according to the set insulin administration information (S1160).
  • the insulin administration device 100 may request biometric information measurement from the biometric information measuring device 50 (S1165).
  • the electronic device 200 may receive administration completion information from the insulin administration device 100 or receive a user input, detect completion of insulin administration, and request biometric information measurement from the biometric information measuring device 50. .
  • the biometric information measuring device 50 may measure the biometric information of the user (S1167) and transmit the measured biometric information to the electronic device 200.
  • the electronic device 200 may receive a blood sugar level of the user from the biometric information measuring device 50.
  • the electronic device 200 may determine whether there is an abnormality in insulin administration based on the received biometric information of the user, and output the determination result (S1175).
  • the electronic device 200 determines that the user is in an abnormal state (side effects), and graphic elements (eg, menus, icons, texts, items, etc.) indicating side effects occur. Can be displayed.
  • the electronic device 200 may output audio, vibration, or the like indicating side effects.
  • the electronic device 200 may transmit a side effect occurrence message to a preset external device.
  • FIG. 12 is a diagram illustrating an example of changing insulin administration information based on biometric information of a user, according to an exemplary embodiment.
  • the insulin administration device 100 may receive insulin prescription information 1210.
  • Insulin prescription information 1210 represents the insulin administration information for the user, as shown in Figure 12, the administration time of insulin, the type of insulin to be administered, the dosage of insulin, the mixing ratio of insulin (different types of Or a combination of insulin).
  • the insulin administration device 100 may receive insulin prescription information from an external device or a server, and automatically set insulin administration information according to the received prescription information. Alternatively, a user may directly input insulin prescription information to the insulin administration device 100 to set insulin administration information.
  • the insulin administration device 100 may set administration time, type of insulin to be administered, insulin dose, mixing ratio of insulin, and the like, and the insulin administration device 100 may be set.
  • the administration information 1220 may be displayed on the display unit.
  • the insulin administration device 100 may request the biometric information of the user to the biometric information measuring device 50 when the time of administration, or when a time before the administration time reaches a certain time.
  • the biometric information of the user may be requested to the biometric information measuring device 50 by a user input.
  • the biometric information measuring device 50 may transmit the measured biometric information of the user to the insulin administration device 100 in response to the biometric information request.
  • the biometric information measuring device 50 may include a user's body temperature, heart rate, pulse rate, pulse variability, blood pressure, sweat, blood sugar, respiration information, oxygen saturation, skin condition, exercise information, diet information, meal amount information, stress information, Sleep information and the like may be transmitted to the insulin administration device 100.
  • the insulin administration device 100 may change insulin administration information based on the received biometric information of the user. For example, the insulin administration device 100 may determine the dosage of insulin in consideration of the user's pre-workout blood sugar level, exercise time, and intensity. If the initially set insulin dose is 20 units, the user's pre-exercise blood sugar level is 100 mg / dL, and the user has run for 40 minutes (high intensity exercise in the middle hours), the insulin administration device 100 administers the set insulin. You can change the amount from 20 units to 19 units, down from 1 unit. However, the present invention is not limited thereto, and the insulin administration device 100 may also change the administration time of insulin, the type of insulin to be administered, and the like, based on the first biometric information (biometric information sensed before the insulin administration) of the user.
  • biometric information biometric information sensed before the insulin administration
  • the insulin administration device 100 may automatically change insulin administration information, and display the changed insulin administration information 1230 on the display unit, as shown in FIG. 12.
  • FIG. 13 is a diagram illustrating an example in which the insulin administration device 100 receives biometric information after completion of insulin administration.
  • the insulin administration device 100 may display a message 1310 indicating completion of insulin administration on the display unit.
  • a message 1310 indicating completion of insulin administration on the display unit.
  • audio, vibration, and the like indicating insulin administration completion may be output.
  • the insulin administration device 100 may determine that insulin administration is complete when the injection port for administering insulin is not in contact with the user's body for a preset time, when all of the set insulin dose is administered to the user. Alternatively, when the insulin administration completion input is received, it may be determined that insulin administration completion.
  • the insulin administration device 100 may request biometric information measurement from the biometric information measuring device 50 and receive biometric information from the biometric information measuring device 50.
  • the insulin administration device 100 may receive a blood sugar level of the user from the biometric information measurement device 50.
  • the insulin administration device 50 may display the received blood sugar level of the user and information 1320 about the normal range of the expected blood sugar level after insulin administration on the display unit.
  • the insulin administration device 100 may determine whether there is an abnormality in insulin administration by comparing the blood glucose level of the current user and the normal range of the blood sugar level.
  • FIG. 14 is a diagram illustrating an example in which insulin administration information is set based on biometric information of a user, according to an exemplary embodiment.
  • the electronic device 200 may receive insulin prescription information.
  • the insulin prescription information 1410 may include an administration time of insulin, a type of insulin to be administered, a dose of insulin, and the like.
  • the electronic device 200 may receive insulin administration information from an external device or a server. Alternatively, a user may directly input insulin prescription information to the electronic device 200.
  • the electronic device 200 may display the acquired insulin prescription information 1410 on the display unit.
  • the insulin prescription information may include the administration time of insulin, the type of insulin to be administered, the dosage of insulin, the mixing ratio of insulin (when different types of insulin are mixed and administered), and the like.
  • the electronic device 200 may request the biometric information of the user from the biometric information measuring device 50.
  • the electronic device 200 may display a message 1420 for selecting whether to request biometric information on the display unit.
  • the electronic device 200 may receive a user input of selecting a 'Yes' button and request the user's biometric information from the biometric information measuring device 50.
  • the biometric information measuring device 50 may transmit the measured biometric information of the user to the electronic device 200 in response to the biometric information request.
  • the biometric information measuring device 50 may include a user's body temperature, heart rate, pulse rate, pulse variability, blood pressure, sweat, blood sugar, respiration information, oxygen saturation, skin condition, exercise information, diet information, meal amount information, stress information, Sleep information and the like may be transmitted to the electronic device 200.
  • the electronic device 200 may set insulin administration information 1430 based on the prescription information and the user's biometric information. For example, the electronic device 200 may determine the dosage of insulin in consideration of the user's pre-workout blood sugar level, exercise time, and intensity. If the initially set insulin dose is 20 units, the user's pre-exercise blood sugar level is 100 mg / dL, and the user has run for 40 minutes (high intensity exercise in the middle hours), the electronic device 200 may adjust the dose of insulin. You can change from 20 units to 19 units with 1 unit reduced. However, the present invention is not limited thereto, and the electronic device 200 may change the administration time of insulin, the type of insulin to be administered, and the like, based on the biometric information of the user.
  • the electronic device 200 may transmit insulin administration information to the insulin administration device 100.
  • the insulin administration device 100 may display the received insulin administration information 1440 on the display unit. In addition, the insulin administration device 100 may set the insulin administration information displayed on the display unit when receiving the input of pressing the 'OK' button.
  • 15 is a diagram illustrating an example of manually setting insulin administration information in an insulin administration device according to one embodiment.
  • the electronic device 200 may display the insulin administration information 1510 on the display unit and transmit the insulin administration information 1510 to the insulin administration device 100.
  • the user may directly input insulin administration information to the insulin administration device 100 to set insulin administration information.
  • the insulin administration device 100 compares the input insulin administration information 1520 with the insulin administration information received from the electronic device 100, and when the insulin administration information is different, a message indicating that administration information is incorrectly input (1530). ) Can be displayed on the display.
  • 16 is a diagram illustrating an example in which an electronic device receives biometric information after completion of insulin administration according to one embodiment.
  • the insulin administration device 100 may transmit insulin administration completion information to the electronic device 200.
  • Insulin administration completion information may be data or a signal indicating that insulin administration has been completed.
  • the electronic device 200 may display a graphic element (for example, a menu, an icon, text, an item, etc.) 1620 indicating completion of insulin administration on the display unit 221. Alternatively, audio, vibration, and the like indicating insulin administration completion may be output.
  • the electronic device 200 may request biometric information measurement from the biometric information measuring device 50 and receive biometric information from the biometric information measuring device 50.
  • the electronic device 200 may receive a blood sugar level of the user from the biometric information measuring device 50.
  • the electronic device 200 may display, on the display, information about the normal blood glucose level of the user and the normal range of the expected blood sugar level after administration of the insulin.
  • the electronic device 200 may determine whether there is an abnormality in the administration of insulin by comparing the current blood glucose level and the normal range of the blood sugar level.
  • 17A and 17B illustrate an example of feeding back side effects to a user when side effects occur due to insulin administration, according to an exemplary embodiment.
  • the electronic device 200 may determine whether the current user's blood sugar level is within a normal range (80 mg / dL to 150 mg / dL), and may determine a side effect when the blood sugar level is outside the normal range. For example, when the blood sugar level of the current user is less than the normal range, it may be determined that the user is in a hypoglycemic state.
  • a normal range 80 mg / dL to 150 mg / dL
  • the determination result of whether a side effect indicating that the user is in a hypoglycemic state may be displayed as a graphic element (for example, a menu, an icon, text, or an item) on the display unit of the electronic device 200.
  • the blood sugar level can be displayed together.
  • the electronic device 200 may output audio, vibration, or the like indicating that the blood sugar state is low.
  • the insulin administration device 100 may determine whether there is an abnormality in insulin administration in the same manner as the electronic device 200 of FIG. 17A, and may determine a result of the message 1720, audio, vibration, or the like. You can output
  • FIG. 18 is a diagram illustrating an example of transmitting a message informing of occurrence of side effects to an external device when side effects occur in administering insulin according to an embodiment.
  • the electronic device (first electronic device) 200 of the first user may display a result of determining that the first user is in a hypoglycemic state (eg, For example, a menu, an icon, text, an item, etc.), audio, and vibration may be output.
  • the first electronic device 200 may transmit a message indicating that the first user is in a hypoglycemic state to the external terminal 400.
  • the first electronic device 200 may transmit a message to the corresponding terminal.
  • the first electronic device 200 may transmit a message to a preset emergency medical center.
  • the first electronic device 200 may transmit a message to the terminal having the closest distance among the external terminals in which the identification information is stored in the first electronic device 200.
  • 19A, 19B, and 20 are diagrams illustrating an authentication method between an insulin administration device and an electronic device according to an embodiment.
  • 19A and 19B illustrate a method of authenticating an insulin administration device 100 in an electronic device 200 according to an embodiment.
  • the insulin administration device 100 and the electronic device 200 may generate and store keys for authentication (S1905 and S1910).
  • the insulin administration device 100 may transmit identification information of the insulin administration device 100 while requesting authentication to the electronic device 200 (S1920).
  • the electronic device 200 may transmit identification information of the electronic device 200 while requesting authentication to the insulin administering device 100.
  • the electronic device 200 receiving the authentication request may transmit a random value to the insulin administration device 100 in operation S1930.
  • the insulin administration device 100 may encrypt the received random value by using a key generated in advance or by using a key downloaded from the authentication server (S1940), and the electronic device 200 converts the encrypted value. (S1950).
  • the encryption method may use a symmetric key method or a public key method.
  • the electronic device 200 may receive the encrypted value, decrypt the received encryption value with a pre-stored key, and determine whether to authenticate the insulin administration device 100 (S1960).
  • the electronic device 200 may transmit insulin administration information to the insulin administration device 100 (S1970).
  • the electronic device 200 does not transmit the insulin administration information to the insulin administration device 100.
  • FIG. 19A illustrates and described an embodiment in which the electronic device 200 authenticates the insulin administering device 100
  • the present disclosure is not limited thereto, and the insulin administering device 100 may authenticate the electronic device 200. .
  • the insulin administration device 100 may generate a pin value and display the pin value generated in the display unit in operation S1915.
  • the electronic device 200 may receive a pin value (S1925) and transmit the same to the insulin administration device 100 (S1935).
  • the insulin administration device 100 may determine whether to authenticate the electronic device 200 by comparing the generated pin value with the pin value received from the electronic device 200 (S1945).
  • the insulin administration device 100 may transmit authentication completion information to the electronic device 200 (S1955), and receive insulin administration information from the electronic device 200 (S1965). .
  • the insulin administration device 100 does not receive insulin administration information from the electronic device 200.
  • FIG. 19B an embodiment in which the insulin administering device 100 generates a pin value and authenticates the electronic device 200 based on the generated pin value is illustrated and described, but is not limited thereto.
  • a pin value may be generated at 200, and the insulin administration device 100 may be authenticated based on the generated pin value.
  • FIG. 20 illustrates a method in which the electronic device 200 and the insulin administration device 100 authenticate each other.
  • the insulin administering device 100 and the electronic device 200 may generate and store a key for authentication (S2010 and S2015). While requesting authentication to the electronic device 200, the identification information and the first random value of the insulin administration device 100 may be transmitted (S2020).
  • the electronic device 200 may encrypt the received first random value by using a key generated in advance or by using a key downloaded from the authentication server (S2025).
  • the electronic device 200 may transmit the identification information, the second random value, and the encrypted first random value of the electronic device 200 while requesting authentication to the insulin administration device 100 (S2030).
  • the electronic device 200 may receive the encrypted first random value, decrypt the encrypted first random value with a pre-generated key, and determine whether to authenticate the electronic device 200 (S2040).
  • the insulin administration device 100 encrypts the received second random value by using a key generated in advance or by using a key downloaded from the authentication server (S2045).
  • the encrypted second random value may be transmitted to the electronic device 200.
  • the electronic device 200 may receive the encrypted second random value, decrypt the encrypted second random value with a pre-generated key, and determine whether to authenticate the insulin administration device 100 (S2060).
  • the electronic device 200 may transmit insulin administration information to the insulin administration device 100 (S2070).
  • the insulin administration device 100 requests and authenticates the electronic device 200 and starts the authentication process.
  • the present disclosure is not limited thereto, and the electronic device 200 may be connected to the insulin administration device 100. You can start the authentication process by making an authentication request.
  • the authentication process described with reference to FIGS. 19A, 19B, and 20 may be performed before wireless communication (eg, Wi-Fi, Bluetooth, etc.) between the insulin administration device 100 and the electronic device 200 is connected, or wireless communication may be performed. This can be done after being connected.
  • the insulin administering device 100 or the electronic device 200 is authenticated through the authentication process, the electronic device 200 until the wireless communication connection between the insulin administering device 100 and the electronic device 200 is stopped.
  • the insulin administration device 100 may transmit insulin administration information.
  • 21 and 22 are block diagrams showing the configuration of an insulin administration device according to one embodiment.
  • the insulin administration device 100 may include a communication unit 110, a control unit 120, and an output unit 130. However, not all illustrated components are essential components. Insulin administration device 100 may be implemented by more components than shown, and insulin administration device 100 may also be implemented by fewer components.
  • the insulin administration device 100 may include a user input unit 150 and a sensor unit in addition to the communication unit 110, the control unit 120, and the output unit 130. 160 and the storage unit 170 may be further included.
  • the communicator 110 may include one or more components for the insulin administration device 100 to communicate with an external device.
  • the communication unit 110 may include a Bluetooth communication unit, a near field communication unit, a WLAN (Wi-Fi) communication unit, a Zigbee communication unit, an infrared data association (IrDA) communication unit, and a WFD (Wi-Fi).
  • Direct communication unit UWB (ultra wideband) communication unit, Ant + communication unit and the like, but is not limited thereto.
  • the communication unit 110 may receive at least one of insulin prescription information, insulin administration information, and biometric information of a user from an external device.
  • the controller 120 may set insulin administration information by using insulin prescription information and biometric information of a user sensed before insulin administration.
  • the controller 120 may control the insulin administration information to be displayed on the display unit 140.
  • the controller 120 may determine whether there is an abnormality in insulin administration using biometric information of the user sensed after insulin administration.
  • the output unit 130 may output the determination result determined by the control unit 120.
  • the output unit 130 may display the determination result on the display unit 140, or output the determination result as audio through the sound output unit 132 or as vibration through the vibration motor 133. .
  • the user input unit 150 means a means for inputting data for the user to control the insulin administration device 100.
  • the user input unit 150 may include a button, a key pad, a dome switch, a touch pad (contact capacitive method, pressure resistive film method, infrared sensing method, surface ultrasonic conduction method, Integral tension measurement method, piezo effect method, etc.), jog wheel, jog switch, etc., but is not limited thereto.
  • the insulin administration apparatus 100 may receive insulin prescription information or receive insulin administration completion input through the user input unit 150.
  • the sensor unit 160 includes various sensors, such as the state of the insulin administration device 100 (eg, whether the insulin administration device 100 is administering insulin to a patient, and the insulin administration device 100 administers insulin). Is completed, or whether the insulin administration device 100 is a state in which all of the set insulin dose is administered to the patient) or a peripheral state of the insulin administration device 100, and detects the detected information. Can be delivered to.
  • the sensor unit 160 may detect whether the needle coupled to the insulin administration device is in contact with the user's body. For example, the sensor unit 160 may detect whether the needle coupled to the insulin administration device is in contact with the user's body by using an optical sensor, a contact sensor, or the like. Accordingly, the controller 120 may determine that insulin administration is completed when the needle does not contact the body of the user for a time set by the user.
  • the sensor unit 160 may detect a residual amount of insulin and transmit the detected residual amount to the control unit 120. Accordingly, the controller 120 may determine whether insulin is being administered to the patient, and may determine whether all of the set insulin dosages are administered.
  • the storage unit 170 may store a program for processing and controlling the insulin administration device 100, and may store input / output data.
  • the storage unit 170 may store insulin administration history information of the user. For example, the time of insulin administration (date, time, etc.), the type of insulin administered, the amount of insulin administered, and the like can be stored.
  • the storage unit 170 may store an expiration date of the insulin embedded in the insulin cartridge mounted on the insulin administration device 100.
  • the storage unit 170 may store information about an available time, an available place, and an available user of the insulin administration device 100.
  • the insulin administration device 100 may be set to the lock mode.
  • the user information received by the insulin administration device 100 (for example, If the face, voiceprint, fingerprint information, etc.) are the same as the stored user information, the lock mode of the insulin administration device may be released.
  • 23 and 24 are block diagrams illustrating a configuration of an electronic device according to an embodiment of the present invention.
  • the electronic device 200 may include a communication unit 210, a control unit 230, and an output unit 220.
  • a communication unit 210 may include a communication unit 210, a control unit 230, and an output unit 220.
  • the electronic device 200 may be implemented by more components than the illustrated components, or may be implemented by fewer components.
  • the electronic device 200 may include a user input unit 240 and A in addition to the communication unit 210, the control unit 230, and the output unit 220.
  • the / V input unit 260 and the storage unit 270 may be further included.
  • the communication unit 210 may include one or more components for performing communication between the electronic device 100 and an external device (for example, a server, an insulin administration device, a biometric information measurement device, etc.).
  • the communication unit 210 may include a short range communication unit 211, a mobile communication unit 212, and a broadcast receiving unit 213.
  • the short-range wireless communication unit 211 includes a Bluetooth communication unit, a near field communication unit, a WLAN (Wi-Fi) communication unit, a Zigbee communication unit, an infrared (IrDA) infrared communication unit, It may include a Wi-Fi Direct communication unit, an ultra wideband communication unit, an Ant + communication unit, and the like, but is not limited thereto.
  • the mobile communication unit 212 transmits and receives a radio signal with at least one of a base station, an external terminal, and a server on a mobile communication network.
  • the wireless signal may include various types of data according to transmission and reception of a voice call signal, a video call call signal, or a text / multimedia message.
  • the broadcast receiving unit 213 receives a broadcast signal and / or broadcast related information from the outside through a broadcast channel.
  • the broadcast channel may include a satellite channel and a terrestrial channel.
  • the electronic device 200 may not include the broadcast receiver 213.
  • the communication unit 210 may receive biometric information of a user from a biometric information measuring device. In addition, the communication unit 210 may transmit the set insulin administration information to the insulin administration device 100, and receive the insulin administration completion information from the insulin administration device 100.
  • the communication unit 210 may receive insulin prescription information from an external device.
  • the communicator 210 may transmit a message including a side effect result of insulin administration to a preset external device.
  • the output unit 220 is for outputting a video signal, an audio signal, or a vibration signal.
  • the output unit 220 may include a display unit 221, a sound output unit 222, a vibration motor 223, and the like.
  • the display unit 221 displays and outputs information processed by the electronic device 200.
  • the display unit 221 may display a result of determining whether the insulin administration information, insulin administration completion information or abnormality of insulin administration.
  • the sound output unit 222 is received or stored from the communication unit 210.
  • the audio data stored in the unit 270 is output.
  • the sound output unit 222 outputs a sound signal related to a function (for example, a call signal reception sound, a message reception sound, and a notification sound) performed by the electronic device 200.
  • the sound output unit 122 may include a speaker, a buzzer, and the like.
  • the sound output unit 222 may output the result of determining whether there is an abnormality in the insulin administration information, insulin administration completion information or insulin administration set to the audio administration.
  • the vibration motor 223 may output a vibration signal.
  • the vibration motor 223 may output a vibration signal corresponding to the output of audio data or video data (eg, call signal reception sound, message reception sound, etc.).
  • the vibration motor 223 may output the result of determining the insulin administration completion information or the abnormality of the insulin administration as audio.
  • the vibration motor 223 may output a vibration signal when a touch is input to the touch screen.
  • the controller 230 controls the overall operation of the electronic device 200.
  • the controller 230 executes the programs stored in the storage unit 270 so that the communication unit 210, the output unit 220, the user input unit 240, the sensor unit 250, and the A / V input unit ( 260) and the like.
  • the controller 230 may set insulin administration information based on the insulin prescription information and the biometric information of the user before insulin administration.
  • the controller 230 may control the insulin administration information to be displayed on the display unit 221.
  • the controller 230 may determine whether there is an abnormality in insulin administration based on the acquired biometric information of the user and output the determination result. For example, the controller 230 may control to display the determination result on the display unit 221 or may output the determination result as audio or vibration.
  • the controller 230 may control to transmit a message including the side effect result to a preset external device.
  • the user input unit 240 refers to a means for a user to input data for controlling the electronic device 200.
  • the user input unit 240 may include a key pad, a dome switch, a touch pad (contact capacitive type, pressure resistive layer type, infrared sensing type, surface ultrasonic conduction type, and integral type). Tension measurement method, piezo effect method, etc.), a jog wheel, a jog switch, and the like, but are not limited thereto.
  • the touch screen 245 may be composed of a touch panel and a display panel.
  • the touch screen 245 may be configured to detect not only the touch input position and the touched area but also the touch pressure.
  • the touch screen 245 may be configured to detect a proximity touch as well as a real-touch.
  • real-touch refers to a case in which a touch tool (for example, an electronic pen, a finger, etc.) is actually touched on the screen
  • proximity-touch refers to This means that the touch tool does not actually touch the screen but approaches a distance from the screen.
  • various sensors may be provided inside or near the touch screen 245 to detect a touch or a proximity touch of the touch screen.
  • An example of a sensor for sensing a touch of the touch screen 245 is a tactile sensor.
  • the tactile sensor refers to a sensor that senses the contact of a specific object to the extent that a person feels or more.
  • the tactile sensor may sense various information such as the roughness of the contact surface, the rigidity of the contact object, the temperature of the contact point, and the like.
  • the proximity sensor 258 is an example of a sensor for sensing a touch of the touch screen 245.
  • the proximity sensor 258 refers to a sensor that detects the presence or absence of an object approaching a predetermined detection surface or an object present in the vicinity without using a mechanical contact by using an electromagnetic force or infrared rays.
  • Examples of the proximity sensor include a transmission photoelectric sensor, a direct reflection photoelectric sensor, a mirror reflection photoelectric sensor, a high frequency oscillation proximity sensor, a capacitive proximity sensor, a magnetic proximity sensor, and an infrared proximity sensor.
  • the user's touch gesture may include a tap, a touch and hold, a double tap, a drag, a pan, a flick, a drag and drop, a swipe, and the like.
  • the sensor unit 250 may include a state of the electronic device 200 or an electronic device ( 200 may detect a state of the surrounding, and transmit the detected information to the controller 230.
  • the sensor unit 250 may include a geomagnetic sensor 251, an acceleration sensor 252, a temperature / humidity sensor 153, an infrared sensor 254, a gyroscope sensor 255, and a position sensor. (Eg, GPS) 256, barometric pressure sensor 257, proximity sensor 258, and RGB sensor (illuminance sensor) 259, but are not limited thereto. Since functions of the respective sensors can be intuitively deduced by those skilled in the art from the names, detailed descriptions thereof will be omitted.
  • the sensor unit 250 may sense a movement of the electronic device 200, a biosignal of a user of the electronic device, a touch signal input to the electronic device, and the like.
  • the A / V input unit 260 is for inputting an audio signal or a video signal, and may include a camera 261 and a microphone 262.
  • the camera 261 may obtain an image frame such as a still image or a moving image through an image sensor in a video call mode or a photographing mode.
  • the image captured by the image sensor may be processed by the controller 220 or a separate image processor (not shown).
  • the image frame processed by the camera 261 may be stored in the storage 270 or transmitted to the outside through the communication unit 250. Two or more cameras 261 may be provided according to a configuration aspect of the electronic device 200.
  • the microphone 262 receives an external sound signal and processes it into electrical voice data.
  • the microphone 262 may receive an acoustic signal from an external device or speaker.
  • the microphone 262 may use various noise removing algorithms for removing noise generated in the process of receiving an external sound signal.
  • the storage unit 270 may store a program for processing and controlling the control unit 230, and may store input / output data.
  • the storage unit 270 may store insulin administration history information of the user. For example, the time of insulin administration (date, time, etc.), the type of insulin administered, the amount of insulin administered, and the like can be stored.
  • the controller 230 may update the insulin administration history information stored in the storage unit 270 whenever the insulin administration completion information is received from the insulin administration device 100.
  • the storage unit 270 may include a flash memory type, a hard disk type, a multimedia card micro type, a card type memory (for example, SD or XD memory), Random Access Memory (RAM) Static Random Access Memory (SRAM), Read-Only Memory (ROM), Electrically Erasable Programmable Read-Only Memory (EEPROM), Programmable Read-Only Memory (PROM), Magnetic Memory, Magnetic It may include a storage medium of at least one type of disk, optical disk.
  • the electronic device 200 may operate a web storage or a cloud server that performs a storage function of the storage unit 270 on the Internet.
  • Programs stored in the storage unit 270 may be classified into a plurality of modules according to their functions.
  • the programs stored in the storage unit 270 may be classified into a UI module 271, a touch screen module 272, and a notification module 273. have.
  • the UI module 271 may provide a specialized UI, GUI, or the like that is linked to the electronic device 200 for each application.
  • the touch screen module 272 may detect a touch gesture on a user's touch screen and transmit information about the touch gesture to the controller 230.
  • the touch screen module 272 according to an embodiment of the present invention may recognize and analyze a touch code.
  • the touch screen module 272 may be configured as separate hardware including a controller.
  • the notification module 273 may generate a signal for notifying the occurrence of an event of the electronic device 200. Examples of events occurring in the electronic device 200 include call signal reception, message reception, key signal input, and schedule notification.
  • the notification module 273 may output the notification signal in the form of a video signal through the display unit 221, may output the notification signal in the form of an audio signal through the sound output unit 222, and the vibration motor 223. Through the notification signal may be output in the form of a vibration signal.
  • Image display method is implemented in the form of program instructions that can be executed by various computer means may be recorded on a computer readable medium.
  • the computer readable medium may include program instructions, data files, data structures, etc. alone or in combination.
  • Program instructions recorded on the media may be those specially designed and constructed for the purposes of the present invention, or they may be of the kind well-known and available to those having skill in the computer software arts.
  • Examples of computer-readable recording media include magnetic media such as hard disks, floppy disks, and magnetic tape, optical media such as CD-ROMs, DVDs, and magnetic disks, such as floppy disks.
  • Examples of program instructions include not only machine code generated by a compiler, but also high-level language code that can be executed by a computer using an interpreter or the like.

Landscapes

  • Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Diabetes (AREA)

Abstract

L'invention concerne un dispositif d'administration d'insuline comprenant : une unité de communication pour demander une mesure d'informations biométriques d'un utilisateur à partir d'un dispositif de mesure d'informations biométriques lorsqu'il est détecté que l'administration d'insuline prend fin, et pour recevoir les informations biométriques en provenance du dispositif de mesure d'informations biométriques ; une unité de commande pour déterminer si un utilisateur est dans un état anormal sur la base des informations biométriques reçues ; et une unité de sortie pour délivrer en sortie les résultats déterminés quant à savoir si l'utilisateur est dans un état anormal.
PCT/KR2016/005161 2015-05-28 2016-05-16 Dispositif d'administration d'insuline et dispositif électronique communiquant avec celui-ci Ceased WO2016190583A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2015-0075367 2015-05-28
KR1020150075367A KR20160139812A (ko) 2015-05-28 2015-05-28 인슐린 투여 장치 및 그것과 통신하는 전자장치

Publications (1)

Publication Number Publication Date
WO2016190583A1 true WO2016190583A1 (fr) 2016-12-01

Family

ID=57392574

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2016/005161 Ceased WO2016190583A1 (fr) 2015-05-28 2016-05-16 Dispositif d'administration d'insuline et dispositif électronique communiquant avec celui-ci

Country Status (2)

Country Link
KR (1) KR20160139812A (fr)
WO (1) WO2016190583A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109360665A (zh) * 2018-08-30 2019-02-19 中南大学 一种用于儿童青少年糖尿病管控的课堂综合管理系统
WO2021113859A1 (fr) * 2019-12-03 2021-06-10 Bigfoot Biomedical, Inc. Détermination du fait que des ajustements de recommandations d'insulinothérapie sont pris en compte

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040015344A (ko) * 2001-07-09 2004-02-18 노보 노르디스크 에이/에스 2개의 휴대용 의료장치 사이에서 데이터 정보를 제어하는방법 및 시스템
KR20080011772A (ko) * 2006-07-31 2008-02-11 (주)옥토메티칼어플라이언스 생체정보 관리 시스템 및 그 운용 방법
JP2009240349A (ja) * 2008-03-28 2009-10-22 Terumo Corp 血糖計及び血糖測定値管理システム
KR20130045982A (ko) * 2011-10-27 2013-05-07 주식회사 바이오닉스 약물 투여 제어 장치 및 제어 방법
JP5561095B2 (ja) * 2010-10-19 2014-07-30 セイコーエプソン株式会社 流体注入システム

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040015344A (ko) * 2001-07-09 2004-02-18 노보 노르디스크 에이/에스 2개의 휴대용 의료장치 사이에서 데이터 정보를 제어하는방법 및 시스템
KR20080011772A (ko) * 2006-07-31 2008-02-11 (주)옥토메티칼어플라이언스 생체정보 관리 시스템 및 그 운용 방법
JP2009240349A (ja) * 2008-03-28 2009-10-22 Terumo Corp 血糖計及び血糖測定値管理システム
JP5561095B2 (ja) * 2010-10-19 2014-07-30 セイコーエプソン株式会社 流体注入システム
KR20130045982A (ko) * 2011-10-27 2013-05-07 주식회사 바이오닉스 약물 투여 제어 장치 및 제어 방법

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109360665A (zh) * 2018-08-30 2019-02-19 中南大学 一种用于儿童青少年糖尿病管控的课堂综合管理系统
WO2021113859A1 (fr) * 2019-12-03 2021-06-10 Bigfoot Biomedical, Inc. Détermination du fait que des ajustements de recommandations d'insulinothérapie sont pris en compte

Also Published As

Publication number Publication date
KR20160139812A (ko) 2016-12-07

Similar Documents

Publication Publication Date Title
WO2015147383A1 (fr) Terminal mobile, et son procédé de commande
WO2017105048A1 (fr) Dispositif électronique souple et procédé de fonctionnement associé
WO2017090810A1 (fr) Dispositif vestimentaire et procédé de fonctionnement correspondant
WO2018143529A1 (fr) Terminal mobile et son procédé de commande
WO2016137268A1 (fr) Procédé de traitement tactile et dispositif électronique pour le mettre en œuvre
WO2018139816A1 (fr) Dispositif électronique et son procédé d'exploitation
WO2016195161A1 (fr) Terminal de type montre et son procédé de commande
WO2016018065A1 (fr) Dispositif et procédé de mesure de glycémie, et dispositif électronique comprenant un module de mesure de glycémie
WO2016137283A1 (fr) Dispositif électronique et procédé de mesure de la composition du corps capable de reconnaître automatiquement la partie du corps devant faire l'objet de la mesure dans le dispositif électronique
WO2016043405A1 (fr) Terminal mobile et procédé associé permettant le passage à une faible puissance conformément à un mouvement
WO2016208835A1 (fr) Montre intelligente et son procédé de commande
WO2016133349A1 (fr) Dispositif électronique et procédé de mesure d'informations biométriques
WO2018009029A1 (fr) Dispositif électronique et son procédé de fonctionnement
WO2020171457A1 (fr) Dispositif électronique comprenant une application de méditation
WO2017099314A1 (fr) Dispositif électronique et procédé de fourniture d'informations d'utilisateur
WO2017039125A1 (fr) Dispositif électronique et procédé de fabrication associé
WO2021091286A1 (fr) Dispositif électronique comprenant un capteur pour détecter une entrée externe
WO2018143509A1 (fr) Robot mobile et son procédé de commande
WO2016195207A1 (fr) Terminal mobile
WO2019050212A1 (fr) Procédé, dispositif électronique et support de stockage utilisés pour la reconnaissance d'empreintes digitales
WO2017119687A1 (fr) Appareil et procédé d'affichage de tableaux dans un dispositif électronique
WO2017030212A1 (fr) Terminal mobile et son procédé de commande
WO2018038545A1 (fr) Procédé, système et terminal de communication mobile pour exécuter une opération prédéterminée pour exécuter une fonction spécifique en réponse à une entrée d'utilisateur d'activation
WO2016125971A1 (fr) Terminal mobile et son procédé de commande
WO2016190583A1 (fr) Dispositif d'administration d'insuline et dispositif électronique communiquant avec celui-ci

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16800223

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16800223

Country of ref document: EP

Kind code of ref document: A1